Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07561619 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Yeast Protein for Muscle Mass

StatusNot Yet Recruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 3 months later Jul 2027 → Nov 2027
See other at-risk trials from University of Alberta

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Sep 2026 to Nov 2026 Show 4 more changesShow less
    • Primary completion pushed from Jul 2027 to Nov 2027
    • Eligibility criteria expanded, about 57 words
    • Secondary endpoint revised
    • Publications: details revised at 6 of 6 entries
  2. Start date: Jul 2026 to Sep 2026v3
  3. Secondary endpoints: details revised at 1 of 1 entryv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Protein supplementation is said to be one of the cost-efficient and practical strategies to meet protein needs for growth and exercise, and can help maximize muscle gain from resistance exercise. It facilitates faster recovery from stress-induced tissue damage and enhances performance output. Protein sources derived from animal products are generally recognized as the highest quality protein. However, altering the protein composition of a protein source can improve the protein quality. The yeast protein supplement the investigators will use in this study has a similar amino acid composition to whey protein, which is derived from an animal product, but it is produced more sustainably. The study aims to compare the effects of yeast and whey protein on muscle mass over 16 weeks.
Trial Details
NCT Number NCT07561619
Lead Sponsor University of Alberta
Conditions
(from sponsor)		 Healthy Adult Participants
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov